Vaginal clear cell adenocarcinoma in an infant

Pediatric Hematology and Oncology

Volumn 13, Issue 6, 1996, Pages 577-580

  Yavuz, Halûk ^a,c   Arslan, Ahmet ^a   Avşar, Ayşe Filiz ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b Türkiye Health and Therapy Foundation Medical Center   (Turkey)

^c Havzan Mahallesi   (Turkey)

Author keywords

hematuria in infant; vaginal clear cell adenocarcinoma

Indexed keywords

ARTICLE; CASE REPORT; CLEAR CELL CARCINOMA; FEMALE; HEMATURIA; HUMAN; HYSTERECTOMY; INFANT; VAGINA BLEEDING; VAGINA CARCINOMA; VAGINA DISCHARGE;

EID: 0029906055     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019609030875     Document Type: Article

References (8)

1. Sagar SM. Oestrogen modulators and clear cell carcinoma of vagina. Lancet. 1987;1:913.
2. Horwitz R, Flannery J, Merino M, Viscoli C, Brennan T. Clear cell carcinoma of the vagina and cervix. Incidence, undetected disease, and diethylstilbestrol. Clin Res 1985;33:524A.
3. Herbst AL, Unfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284:878-881.
4. Herbst AL, Cole P, Norusis MJ, Welch WR, Scully RH. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979;135:876-886.
5. Jones WB, Koulos JP, Saigo PE, Lewis JL. Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974-1984. Obstet Gynecol. 1987;70:573-577.
6. Melnick S, Cole P, Anderson D, Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. N Engl J Med. 1987;316:514-516.
7. Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL. Human papillomavirus detection and p53 expression in clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994;84:404-408.
8. Tanaka H, Tabata T, Yanase H, et al. Clear cell adenocarcinoma of the vagina in a young female, treated by combination chemotherapy (local and systemic chemotherapy), complicated with chromosomal abnormality. Obstet Gynecol 1994;55:259-264.